Coordinate and cooperative roles for NF-AT and AP-1 in the regulation of the murine IL-4 gene  by Rooney, John W. et al.
Immunity, Vol. 2, 473-493, May, 1995, Copyright 0 1995 by Cell Press 
Coordinate and Cooperative Roles for NF-AT and AP-1 
in the Regulation of the Murine IL-4 Gene 
John W. Rooney,** Timothy Hoey,t 
and Laurie H. Glimche&§ 
‘Department of Genetics 
Harvard Medical School 
Boston, Massachusetts 02115 
TTularik, Incorporated 
270 East Grand Avenue 
South San Francisco, California 94080 
*Department of Cancer Biology 
Harvard School of Public Health 
Boston, Massachusetts 02115 
SDepartment of Medicine 
Harvard Medical School 
Boston, Massachusetts 02115 
Summary 
The transcription factor NF-AT plays an essential role 
in the inducible transcription of several cytokinegenes 
during T cell activation. The distal NF-AT site of the 
murine IL-2 promoter binds both NF-AT and AP-1 pro- 
teins, and thus represents a composite regulatory site 
that integrates Ca*+- and PKCdependent signaling 
pathways in T cell activation. However, the individual 
contributions of the NF-AT and AP-1 components to 
promoter activity via this composite site have not been 
resolved, owing to the absence of a clearly defined 
AP-1 binding site, which, when mutated abolishes 
AP-1 binding. We describe here an apparently analo- 
gous NF-ATIAP-1 composite site in the murine IL-4 
promoter, which can be mutated to selectively block 
the recruitment of each component. We show that the 
cooperative and coordinate involvement of both NF- 
AT and AP-1 is necessary for full activity of the NF-AT/ 
AP-1 composite site, and, ultimately, the entire IL-4 
promoter. 
Introduction 
Production of cytokines produced by activated T cells, 
such as interleukin-2 (IL-2), IL-3, IL-4, IL-5, IL-6, granulo- 
cyte-macrophage colony-stimulating factor (GM-CSF), tu- 
mor necrosis factor a (TNFa), and interferon-y (IFNy), has 
been shown to occur predominantly at the level of tran- 
scription and can be blocked by the immunosuppressive 
drug cyclosporin A (CsA) (reviewed by Rao, 1994). Impli- 
cated in the transcriptional regulation of many of these 
cytokine genes is the transcription factor, nuclear factor 
of activated T cells (NF-AT). That the calcium- and calmod- 
ulin-dependent phosphatase calcineurin is thought to reg- 
ulate the phosphotylation and subcellular localization of 
NF-AT (Jain et al., 1993b), and is also a target for CsA 
(Schreiber and Crabtree, 1992; Liu et al., 1991) suggests 
that NF-AT plays a key role in the regulation of cytokine 
gene expression. Indeed, binding sites for NF-AT have 
been characterized in the promoters of IL-2, IL-3, IL-4, 
GM-CSF, and TNFa (Rao, 1994). It is now apparent tt 
not one, but many individual NF-AT-like proteins encod 
by individual genes, differentially spliced mRNAs, or bo 
make up an NF-AT family of transcription factors. Alrea 
characterized members of this family include the hum 
and murine forms of NF-ATc (Northrop et al., 1994) a 
NF-ATp (McCaffrey et al., 1993). 
Upon activation of T helper (Th) cells via the T cell reef 
tor, twosignaling pathways are induced: aCa*-depends 
pathway activated by Ca2+ release from the endoplasn 
reticulum, and activation of protein kinase C (PKC; Ri 
1991). These pathways can be mimicked by the calcii 
ionophores and phorbol esters, respectively. Maximal 
duction of many T cell cytokine genes requires treatmc 
of cells with both calcium ionophores and phorbol este 
suggesting that both Ca2+- and PKCdependent pathwt 
are utilized. Of note has been the recent discovery of 1 
calcium- and PKCdependent MAP kinases, JNKl a 
JNKP, which phosphorylate the Jun activation domain o 
in response to both signaling pathways (Su et al., 199 
The first, and most extensively characterized, NF- 
binding site was the distal NF-AT site of both the burr 
(Boise et al., 1993; Northrop et al., 1993) and murine (J 
et al., 1992, 1993a) IL-2 promoters, to which two cc 
ponents were shown to bind: one, which was calcii 
inducible CsA-sensitive (NF-AT), and asecond, which Y 
PKC-inducible CsA-insensitive (AP-1). Thus, this site rf 
resents a composite binding site, which allows for a con 
natorial interaction between two different classes of tr 
scription factors, perhaps providing a greater sensitivi? 
responsiveness to diverse stimuli (Miner and Yamamc 
1991). Because the recruitment of AP-1 at the IL-2 NF-r 
AP-1 composite site depends predominantly on the pr 
ence of bound NF-AT and not on a clearly defined A 
binding site (Jain et al., 1993a; Boise et al., 1993), 
relative role of each component in the transcriptional ac 
ity of the NF-AT/AP-1 composite site has been impossi 
to determine. 
We describe here a similar but distinct NF-ATIAP-1 c( 
posite site in the murine IL-4 promoter. Transfection ( 
helper clones with linker-scanning mutants identify 
AP-1 binding site necessary for inducible IL-4 promc 
activity located immediately upstream of the NF-AT 
spanning -67 to -74. AP-1 proteins bind to this site I 
PKC-dependent, calcium-independent, and CsA-inse 
tive manner that is dependent on both integrity of this $ 
and NF-AT binding to the adjacent NF-AT site. DNA 
footprint assays indicate clearly that the NF-AT and A 
components bind with strong cooperativity in vitro. Wt 
W. R. and L. H. G.) previously reported on the basil 
gel shift assays that an NF-AT component lacking an A 
component binds to the IL-4 NF-AT site spanning -6 
-74 (Rooneyet al., 1994). However, these studies used 
oligonucleotide spanning -60 to -79, and thus we faile 
detect the AP-1 component that binds to the AP-1 binc 
site located from -84 to -91 (Rooney et al., 1994). Stuc 
comparing multimerized IL-4 NF-AT/AP-1 reporter ( 
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Figure 1. A Site Searing Homology to OAP40 
Is Necessary for Inducible IL4 Promoter Ac- 
tivity 
The Th2 cell clone, DIO, was transfected with 
20 pg of the indicated reporter constructs. After 
transfection (24 hr), the cells were induced by 
transferring to 100 mm2 tissue culture dishes 
coated with anti-CD3 (induced), or dishes that 
were uncoated (uninduced). Cells were har- 
vested 1 day later, and relative CAT activity was 
determined. The results shown are averages of 
three independent experiments. 
structs with analogous constructs containing mutated 
AP-1 sites, when cotransfected with either wild-type or 
dominant-negative c-Fos and cJun expression con- 
structs, reveal a corresponding in vivo functional coopera- 
tivity between NF-AT and AP-1. Moreover, these cotrans- 
fections studies reveal the individual contributions of 
NF-AT and AP-1 to total NF-AT-mediated transactivation, 
which until now had been undetermined. We show that 
the AP-1 component binding to the IL-4 NF-AT/AP-1 com- 
posite site may contain Fra-1, Fra-2, JunB, and JunD. Al- 
though the AP-1 family members utilized bythiscomposite 
site differ from those reported to be present in the IL-2 
NF-AT/AP-1 site, we show that the two composite sites are 
functionally interchangeable and do not, by themselves, 
determine Thl/Th2-specific promoter activity as deter- 
mined by experiments in which Thl and Th2 cell clones 
were transfected with IL-2 and IL-4 promoter constructs 
in which their NF-AT/AP-1 composite sites had been 
swapped. 
Results 
Linker-Scanning Mutagenesis Functionally Defines 
an AP-1 Element Necessary for Inducible 
IL-4 Promoter Activity 
A previous study of the murine IL-4 promoter in the Th2 
cell clone DlO had determined that the region spanning 
-80 to -100, when mutated, reduced inducible promoter 
activity to levels of approximately 30% compared with the 
wild-type construct (Todd et al., 1993). To delimit further 
the cis element(s) responsible for this activity, finer 4 bp 
linker-scanning mutageneses were done. To assay for 
function of these constructs, wechose to use the nontrans- 
formed Th2 cell clone, DlO, whose behavior in culture we 
feel more approximates the in vivo environment, com- 
pared with studies using “immortalized” thymoma cell 
lines. As reported previously (Rooney et al., 1994), the 
mutations in the NF-AT binding site adjacent to this area 
(A-72 to -75, and A-76 to -79) completely blocked induc- 
ible activity (Figure 1). Mutations in the -80 to -100 region 
upstream from the NF-AT site defined an inducible re- 
sponse element from -84 to -91, which overlaps a 
sequence with an 818 bp homology to a region in the 
human IL-2 promoter reported to bind the factor, octamer- 
associated protein (OAP40; Ullman et al., 1991, 1993). 
Point mutations in this site reduced IL-2 promoter activity 
in transfected Jurkat cells to levels approximately 30% 
of that found with the unmutated IL-2 promoter construct 
(Ullman et al., 1991). 
NF-AT and AP-1 Proteins Bind Cooperatively to their 
Cognate Binding Sites In the IL-4 Promoter in a 
Manner that Is Dependent upon NF-AT Binding 
The antigen receptor response element (ARRE-1) in the 
IL-2 promoter is a composite element that binds Ott-1 and 
an associated protein, OAP40 (Ullman et al., 1993). The 
OAP40 binding activity was found to contain cJun and 
JunD proteins. The affinity of this site for c-Jun and JunD 
alone was weak, but was significantly greater in the pres- 
ence of Ott-1, indicating a strong cooperativity between 
the two factors. Mutations in the OAP40 site reduced in- 
ducible IL-2 promoter activity in transfected Jurkat cells 
to levels of 300/b compared with wild type (Ullman et al., 
1991). Because of the striking sequence homology of this 
sequence to that in the IL4 promoter, and the similar effect 
that the mutation of this site had on IL4 promoter activity, 
we investigated whether AP-1 proteins could bind at this 
site. Therefore, DNAse I footprint analyses were done on 
the IL4 promoter using purified bacterially expressed 
AP-1 proteins (Figure 2A). No footprint was seen using 
either cJun or c-Fos protein alone, or with cJun and c-Fos 
proteins together (Figure 2A, lanes 2-4) although these 
proteins were able to footprint the AP-1 site in the IL-2 
promoter in parallel experiments (data not shown). The 
inability of AP-1 to bind to the IL4 OAP40 site could be 
explained by the lack of an adjacent binding factor, in this 
case NF-AT, whose binding to its cognate site would provide 
a requisite degree of positive cooperativity allowing for AP-1 
binding, perhaps similar to what occurs between AP-1 and 
NF-AT at the distal NF-AT site in the IL-2 promoter. To test 
this hypothesis, recombinant NF-ATp or NF-ATc proteins 
were included, along with cJun proteins, c-Fos proteins, 
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Figure 2. NF-AT and AP-1 Proteins Bind Cooperatively to the NF-AT and OAP Sites. Respectively, in the IL4 Promoter 
(A) Indicated amounts of purified recombinant NF-ATc, NF-ATp, cJun, and c-Fos proteins were incubated with a Klenow end-labeled IL4 pron 
fragment (x 157 to +66), digested with DNAse I, and analyzed on 6% polyacrylamide-46% urea gels. 
(B) Schematic summary of DNAse I footprinting analyses. Arrows signify nucleotide bases protected from DNAse I digestion. Asterisks ds 
hypersensitive sites. No AP-1 footprint was seen near the most proximal NF-AT site. 
or both, in DNAse I footprint analyses. Upon addition of 
NF-AT proteins to footprinting reactions containing AP-1 
proteins, a region directly over the OAP binding site be- 
comes protected, clearly indicating the dependency upon 
NF-AT for OAP40 site binding (Figure 2A, compare lane 
4 with lane 10; Figure 28 for summary of binding results). 
Furthermore, a reciprocal positive cooperation by AP-1 
proteins on NF-AT binding can be seen by comparing NF- 
ATc or NF-ATp alone (i.e., Figure 2A, lane 6) with NF-AT 
plus AP-1 proteins (i.e., lane 10). c-Fos protein appeared 
unable to associate with NF-ATc or NF-ATp without cJun 
(i.e., Figure 2A, lane 7) and, when included in reactions 
containing c-Jun and NF-ATclNF-ATp, provided no 
greater protection of the OAP site than with NF-ATclNF- 
ATp and cJun alone (Figure 2, compare lanes 6 and lo), 
suggesting that cJun-cJun homodimers bind with higher 
affinity to this site. Based on the above data, we now refer 
to the the IL-4 OAP binding site as an AP-1 site. 
To test our hypothesis another way, we utilized 4 bp 
linker-scanning mutants of the IL-4 promoter in DNAse I 
footprint studies (Figure 3). A mutation that had prevented 
NF-AT binding in gel shift studies previously published 
(Rooney et al., 1993) also prevented the binding of NF-ATc 
and NF-ATp proteins in footprint assays (A-76 to -79; 
Figure 3, lanes 5-6). More importantly, this same NF 
site mutation prevented AP-1 proteins from binding to 
adjacent OAP40 site. Also can be seen is the differer 
owing to positive cooperativity between the two sites 
the footprints over the NF-AT site obtained from promc 
fragments with intact AP-1 sites (i.e., Figure 3, lane 
versus those with mutations in the AP-1 site (i.e., Fig 
3, lane 15). AP-1 proteins clearly increase the affinit 
NF-AT proteins for their cognate binding sites. Th 
assays also reveal that the same mutations in the A 
site that block inducible promoter activity in transient tn 
fections, also block binding of AP-1 proteins (mutati 
A-64 to -67, A-66 to -91; Figure 3, lanes 13-16, la 
17-20, respectively), whereas those that did not af 
function also had no effect on binding of either NF-A 
AP-1 proteins (A-60 to -63, A-92 to -95, A-96 to - 
A-100 to -103; Figure 3, lanes 9-12,21-24,25-26, 
29-32, respectively). 
It is also of interest to note that AP-1 proteins, ei 
alone or with NF-AT, fail to protect any region of the 
promoter other than the AP-1 site. Four distinct reg 
protected by NF-AT proteins were located at (-57 to - 
(-75 to -62) (-160 to -147) and (-162 to -170) car 
ring with previous reports of NF-AT-mediated binding 
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Figure 3. The DNA Regions Required for AP-1 Binding Exactly Correlate with those Required for lnducibility In Vivo 
DNAse I footprinting was carried out as in Figure 2 using IL-4 promoter fragments derived from the linker-scanning mutant reporter plasmids used 
in the transient transfection analyses 
function occurring at or near the66 locations (Rooney et 
al., 1993; Szabo et al., 1993; Hodge et al., 1995). 
Characterization of the NF-ATIAP-1 Complex 
from Th2 Nuclear Extracts 
To characterize the protein6 that bind to the NF-AT and 
AP-1 binding sites in cellular extracts, gel shift assays were 
performed using nuclear protein extracts prepared from 
the Th2 ceil clone DlO. Gel shift assays using nuclear 
extracts from DlO ceils stimulated with anti-CD3 and an 
oiigonucieotide encompassing -61 to -66 revealed two 
complexes; an upper and lower (Figure 4A, lane 1). Muta- 
tions in the AP-1 site (A-64 to -87 and A-88 to -91; 
Figure 4A, lanes 4 and 5) resulted in the formation of only 
the lower complex. Mutation of either the NF-ATsite (A-76 
to -79) alone (Figure 4A, lane 2), or both the NF-AT site 
(A-76 to -79) and the AP-1 site (A-84 to -87) (Figure 
4A, lane 7), resulted in the complete loss of binding. Thus, 
while the formation of the lower complex required an intact 
NF-AT site, upper complex formation required both an in- 
tact NF-AT site and an intact AP-1 site, indicating a strong 
degree of cooperativity between these two binding sites. 
When used as cold competitors in gel shift assays, ail 
oiigonucieotides bearing intact NF-AT sites abolished for- 
mation of both complexes (Figure 46, lanes 2-5). Cold 
competitor oiigonucieotides bearing mutations in the OAP 
site, but retaining an intact NF-AT site, were still able to 
compete away both the upper and lower complexes (data 
not shown). Also, an oiigonucleotide that contains no sig- 
nificant homology to the AP-1 site in the IL-4 NF-AT/AP-1 
composite site, but that contains a consensus AP-1 site 
was able to compete away the upper complex (Figure 46, 
lanes 8-9). Ail these data suggest that the lower complex 
corresponds to NF-AT, and the upper complex corre- 
sponds to NF-AT plus AP-1, a pattern of complex formation 
similar to that obtained using an oiigonucieotide con- 
taining the IL-2 distal NF-AT site. 
To determine the pattern of inducibiiity of the com- 
plexes, nuclear extracts were prepared from DlO ceils 
treated with a variety of agents and were used in gel shift 
assays (Figure 4C). The lower complex is calcium iono- 
phore-dependent (Figure 4C, lane 5) CsA sensitive (lane 
6), and neither induced byphorboi myristate acetate(PMA) 
alone (lane 7), or augmented by PMA when cotreated with 
calcium ionophore (compare lanes 5 and 9); ail of which 
are characteristic of an NFAT complex lacking an AP-1 
component (Rooney et al., 1993). in contrast, formation 
of the upper complex requires, in addition to treatments 
that induce NF-AT, either PMA or anti-CD3 (Figure 4C, 
lanes 3 and 9), both of which activate a protein kinase 
C-dependent signaling pathway known to be required for 
AP-1 binding. 
The Contrlbution of AP-1 Proteins to 
NF-AT-Mediated Transactivation of the 
IL-4 NF-ATIAP-1 Composite Site 
To assess directly the functional in vivo contribution of 
AP-1 proteins in the NF-AT-mediated transactivation of 
the IL-4 NF-AT/AP-1 site, muitimerized IL-4 NF-ATIAP-l- 
CAT reporter constructs were cotransfected along with 
AP-1 expression constructs into the Th2 ceil clone, DlO. 
To determine the relative contribution that the NF-AT or 
AP-1 sites made to the total level of activity, four muitimer- 
ized NF-AT/AP-l-CAT constructs were used which con- 
tained unaltered wild-type NF-AT and AP-1 sites (5x 
wtNF-AT/wtAP-1), mutated NF-AT sites and unaltered 
AP-1 sites (5 x mtNF-ATlwtAP-1), unaltered NF-AT and 
mutated AP-1 sites (5 x wtNF-AT/mtAP-1), and both mu- 
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Figure 4. Analysis of NF-AT and AP-1 Proteins in DlO Extracts 
(A) Nuclear extracts were prepared from DlO cells treated with plate- 
bound anti-CD3 for 2 hr as described in Experimental Procedures and 
used in EMSAs with end-labeled oligonucleotides corresponding to 
(-88 to -81) of the IL-4 promoter containing the NF-AT and AP-1 
binding sites. The sequence of the mutant probes corresponds to the 
mutations used in transient transfection analyses (Figure 1). Arrows 
indicate the location of the upper and lower bands containing the NF- 
tated NF-AT and mutated AP-1 sites (5 x mtNF-ATlmtAP-’ 
These constructs were cotransfected with varying amoun 
of c-F08 or c-Jun into DlO cells, and assays for their r 
sulting CAT expression in response to anti-CD3 were pe 
formed (Figure 5A). With no cotransfected c-Fos or CJU 
the unmutated multimer construct was induced 15fold upc 
treatment with anti-CD3. In contrast, the 5x wtNF-A 
mtAP-1-multimer construct was only induced Mold. Thu 
more than half of the inducible activity of the composi 
NF-ATIAP-1 site can be attributed to the AP-1 site. Expre 
8ion of cJun and c-Fos both significantly augmented act1 
ity of the unmutated construct, whereas the multimer co 
struct containing mutated AP-1 sites was unaffected I 
even the highest amounts of cotransfected c-Fos ar 
cJun, indicating the augmentation was occurring throu! 
the AP-1 site. Also, cotransfection of expression vectc 
containing cDNAs encoding other AP-1 proteins (Fos 
Fra-1, Fra-2, JunB, and JunD) were also able to augme 
activity of this reporter construct, indicating that when ( 
topically overexpressed, AP-1 family members posses: 
degree of functional redundancy in regard to the IL 
NF-ATIAP-1 site. No inducible activity was Seen using 
ther the 5 x mtNF-ATMAP- construct (Figure 5) or t 
5x mtNF-ATlmtAP-1 construct (data not shown), si 
gesting that transactivation by AP-1 proteins, like the bir 
ing of AP-1 proteins to the AP-1 site, is NF-AT depende 
The role of AP-1 proteins in the activation of the NF-1 
AP-1 site was also confirmed in cotransfection expt 
ments using dominant negative forms of c-Fos and CJ 
(Figure 56). AFosB (Nakabeppu and Nathans, 1991) 8 
JunA9 (Lloyd et al., 1991) are variant8 in which the acti! 
tion domain has been truncated, resulting in the inhibit1 
of AP-1 transcriptional activity. Both AFosB and Jun 
inhibited expression of the 5 x wtNF-AT/wtAP-1 constn 
but had no effect on the 5 x wtNF-AT/mtAP-1 constn 
indicating that these dominant negatives are act 
through the AP-1 site. 
Fra-1, Fra-2, JunB, and JunD Are the Predominan 
Members of the AP-1 Component that Binds 
to the IL-4 NF-ATIAP-1 Composite Site 
To determine the predominant AP-1 proteins that ass 
ate with NF-AT at the IL4 NF-ATIAP-1 site, monocle 
antibodies specific to each AP-1 family member were u: 
in gel shift assays. Antibodies against Fra-1, Fra-2, Ju 
and JunD, but not c-Fos, FosB, or cJun, reacted with 
NF-ATlAP- complex obtained in gel shifts using the I 
NF-ATIAP-1 oligonucleotide and nuclear extracts fr 
AT and AP-1 components, and the NF-AT component alone, res 
tively. 
(6) EMSAs performed using end-labeled wild-type probe with indic 
molar excesses of unlabelled competitor oligonucleotides. The wt 
to -80) is lacking the AP-1 binding site. The MRE oligonucla 
contains the AP-1 site from the human metallothionein promote 
(C) EMSAs performed using nuclear extracts prepared from DlO 
treated for 2 hr with 1 &ml cyclosporin A, plate-bound anti-U 
uM ionomycin, 10 nglml PMA, either alone or in combination! 
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Fold Induction with cFos Figure 5. Transactivation Via the AP-1 Site by AP-1 Proteins In Vivo 
DIO cells were transfected with 20 pg of 5 x 
wtNF-AT/v&P-l (multimerized wild type -66 
to -61) 5 x wtNF-AT/mtAP-1 (multimerized 
-66 to -61 A(-64 to -67) or 5x mtNF-AT/ 
wtAP-1 (multimerized -66 to -61 A(-76 to 
-79). along with the indicated amounts of ex- 
pression vectors containing the murine cDNAs 
for c-Fos and cJun (A), or the dominant- 
negative AFosB and JunA9 (8). Empty expres- 
sion vector was added to bring the total amount 
of DNApertransfection to40 ng.Aftertransfec- 
tion (24 hr), the cells were induced with plate 
bound anti-CD3 and incubated for an additional 
24 hr before harvest and determination of CAT 
activity. The results shown are averages of 
three independent experiments. 
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DlO Figure 6. Fra-1, Fra-2, JunB, and JunD 
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Nuclear extracts were prepared from AE7 
m9a8aaaa33 DlO clones induced for 2 hr with plate-b0 
anti-CD3 and used in EMSA analyses with 8 
bodies specific for murine NF-AT, c-Fos, Fc 
Fra-I, Fra-2, cJun, June, and JunD. Ra 
anti-mouse immunoglobulin G and bovine 
rum albumin were included as controls. f 
the upper complex consisting of NF-AT 
AP-1 proteins formed due to the conditior 
preincubation with antibodies. 
antiCD3-treated DlO cells (Figure 6). Owing to the condi- 
tions of the supershift binding reactions, only the upper 
NF-AT/AP-1 complex forms. The lower complex con- 
taining NF-AT alone is not seen under these condtions. 
To rule out the possibility that the c-Fos, FosB, and cJun 
antibodies do not function in our gel shift assays and to 
verify the presence of AP-1 proteins in the nuclear ex- 
tracts, gel shifts were performed using an oligonucleotide 
containing the human metallothionein response element 
(MRE), which contains a consensus AP-1 binding site. All 
AP-1 antibodies reacted with the complexes formed using 
the MRE, suggesting that c-Fos, FosB, and cJun are not 
present in the IL4 NF-ATIAP-1 complex, but are present 
in nuclear extracts from anti-CD3treated DlO cells. 
Differential Utilization of AP-1 Family Members by 
the IL-2 and IL-4 NF-ATIAP-1 Composite Sites 
Does Not Determine Tissue-Specific 
Promoter Activities 
The AP-1 family members present in the IL4 NFAT/AP-1 
complex differ from those reported for the IL-2 NF-AT/AP-1 
complex, in which c-Fos, Fra-1, Fra-2, and JunB, but not 
FosB, cJun, or JunD, have been detected. In accord- 
ance with these reports, antibodies specific to c-Fos, 
Fra-1, Fra-2, and JunB, but not FosB, cJun, or JunD, 
supershifted NF-AT/AP-1 complexes in gel shift experi- 
ments using the IL-2 distal NF-AT site with Thl (AE7) and 
Th2 (DlO) nuclear extracts (data not shown). This raised 
the possibility that differential recruitment of AP-1 family 
members by NF-AT at the IL-2 and IL-4 NF-AT/AP-1 com- 
posite sites may determine Thl- and Th2-specific expres- 
sion of IL-2 and IL-4 genes, respectively. Different AP-1 
proteins acting in conjunction with the glucocorticoid re- 
ceptor at the glucocorticoid response element (GRE)/AP-1 
composite element, plfG, have been shown to confer dis- 
tinct regulatory effects, ranging from repression to en- 
hancement (Miner and Yamamoto, 1992). The involve- 
ment of different AP-1 proteins to the IL-2 and IL4 NF-AT/ 
AP-1 composite sites could be attained by limiting 
amounts of a particular AP-1 protein(s) in Th2 or Thl cells 
or, alternatively, by differences in the relative affinities of 
the different NF-ATIAP-1 sites for different AP-1 proteins. 
To investigate these possibilities, gel shift assays were 
performed using nuclear extracts prepared from the Thl 
clone, AE7 (Figure 6). Both extracts contained all AP-1 
family members as determined by reaction of AP-1 anti- 
bodies to complexes bound to the MRE consensus AP-1 
site. Furthermore, identical profiles of AP-1 proteins w 
found in AE7 and DlO nuclear extracts using the IL4 
ATIAP-1 site, suggesting that it is the individual NF- 
AP-1 composite binding site that determines the differ 
tial recruitment of AP-1 family members, and not dil 
ences of AP-1 binding activities inherent in Thl and ’ 
nuclear extracts. 
To assess more rigorously the possible contributio 
the IL-2 and IL4 NF-ATIAP-1 composite elements to 
sue-specific promoter activity, transient transfecti 
were done in AE7 (Thl) and DlO (Th2) cells using 
and IL4 promoter constructs in which the NFATIP 
composite elements had been swapped (Figure 7). 1 
the cell clones AE7 and DlO represent phenotypically 
and Th2 clones is confirmed by their ability to selecti 
express either the IL-2 or IL4 reporter constructs, and 
both. Substitution of the IL-2 NF-AT/AP-1 site for the 
NF-AT/OAP site in the IL-4 promoter resulted in no a 
ation of IL4 promoter activity in either AE7 or DlO c 
Likewise, the reciprocal substitution in the IL-2 prom 
had no effect on the pattern of IL-2 expression in ei 
AE7 or DlO cells. Similarly, it was found that multin 
of the IL-2 and IL4 NF-AT/AP-1 sites function essent 
identically in transfected AE7 or DlO cells (data 
shown). Thus, although it cannot be ruled out that tt 
composite elements that utilize overlapping yet dis 
groups of AP-1 proteins contribute to differential prom 
activities, it is clear that these elements, by themsel 
are not sufficient to confer Thl/Th2-specific pattern 
expression on their downstream promoters. 
Discussion 
Upon stimulation of T cells via the T cell receptor, at I 
two signal transduction pathways are initiated bl 
creases in intracellular calcium and the activation of I 
(Rao, 1991). Both signaling pathways are necessar 
the transcriptional activation of many cytokine gene: 
inferred by the dependency upon agents that stimt 
both pathways. For example, both PMA (which activ 
PKC) and calcium ionophore are required for the trans 
tion of 11-2; treatment with either agent alone does not r 
mally induce transcription (Weiss et al., 1964; Wisko 
al., 1965). How these two stimuli are integrated to rl 
in transcription is not entirely known. For the IL-2 ge 
occurs at two levels: through the use of second mes 
gers, such as recently described PMAIcalcium-induN 
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DlO (Th2) AE7 (Thl) Figure 7. The IL-2 and IL4 NF-ATIAP-1 Com- 
posite Sites Are Functionally Interchangeable 
i;Ej (/X1, 
within the IL-2 and IL4 Promoters 
AE7 and DlO cells were transfected with 20 
pg of reporter constructs containing the IL-2 
promoter (-319 to -7), the IL-4 promoter (-157 
to +99). and IL-2 and IL4 promoter constructs 
in which regions encompassing the NF-AT/ 
t ;g i 
3 AP-1 composite sites were exchanged as dia- 
8 a^ * C : 
t q f; 
grammed (indicated as ANF-AT constructs). 
5 -’ 
E 
: ^ 8 




? r^ 2 After transfection (24 hr), the cells were in- 
p z 
$ = i duced bytransferring to 100mm2tissueculture 
dishes coated with anti-CD3 (induced), or 
dishes that were uncoated funinduced). Cells 
were harvested 1 day later,‘ and relative CAT 
activity was determined. The results shown are 
averages of three independent experiments. 
MAP kinases JNKl and JNK2, and at the promoter level 
through the combinatorial effects by PKC-dependent and 
calcium-dependent transcription factors, such as AP-1 
and NF-AT, respectively. Interestingly, a single cis ele- 
ment in the IL-2 promoter, the distal NFAT site, can coop- 
eratively bind both NF-AT and AP-1 proteins, and thus 
represents a true composite site that integrates both sig- 
naling pathways. 
Unlike the IL-2 promoter, which has been extensively 
characterized and whose regulation involves both PKC- 
and calcium-dependent transcription factors, the IL4 pro- 
moter has been shown to be regulated predominantly by 
the calcium-dependent transcription factor NF-AT. In- 
deed, treatment with calcium ionophore or transfection 
with a constitutively active form of calcium-dependent 
phosphatase, calcineurin, have been reported to be suf- 
ficient for maximal induction of the IL4 gene (Rooney 
et al., 1993; Kubo et al., 1994). We believe that these 
studies suggest instead that the overutilization of calcium- 
dependent signaling pathway(s) may suffice for maximal 
IL4 transcription, and that this does not preclude the re- 
quirement for a PMAdependent pathway in the presence 
of more physiologic level8 of intracellular calcium release. 
Our report of the involvement of AP-1 proteins being nec- 
essary for normal level8 of IL4 promoter activity implicates 
the requirement of a PMAdependent factor for the tran- 
scriptional regulation of the IL4 gene. Similar to the distal 
NF-ATsiteof the IL-2 promoter, AP-1 proteins bind cooper- 
atively with NF-AT to an analogous, but distinct, site in 
the IL4 promoter. Also similar is the absolute requirement 
of the integrity of each of these sites for the activity of their 
downstream promoters(Ullman et al., 1991). In each case, 
the involvement of AP-1 proteins is dependent upon the 
presence of NF-AT; AP-1 proteins are unable, by them- 
selves, to bind the IL-2 or IL4 NF-AT/AP-1 composite sites 
(Figure 2A, lanes 2-4; T. H., unpublished data). Further- 
more, for the IL-2 site, all mutations that prevent the bind- 
ing of AP-1 also prevent the binding of NF-ATdue to strong 
cooperative binding. As a result, nodefinitive role for either 
NF-AT alone, or for the contributing role of AP-1 pro- 
teins acting through this element, could be accurately as- 
sessed. 
The IL4 NF-AT/AP-1 site offered a unique opportunity 
to investigate the contributions of the NF-AT and AP-1 
components due to the presence of an AP-1 binding site 
that is functionally and spatially discrete from the adjacent 
NF-AT binding site. By selectively mutating this AP-1 site, 
NF-AT is still able to bind, albeit with slightly less affinity 
due to the loss of cooperativity of binding contributed by 
the presence of AP-1. Transfection experiments employ- 
ing constructs mutated in the OAP site in the context of 
the entire IL4 promoter result in an inducible promoter 
activity of only one-third of that obtained with an unmutated 
promoter construct. In multimerized reporter constructs 
mutated in this site, a similar decrease in the level of induc- 
ible activity compared with that of the unmutated multimer 
construct was seen. Thus, only one-third of the total NF- 
AT-mediated transactivation is directly attributable to NF- 
AT alone. The one-third level of NFAT-mediated transacti- 
vation was also obtained by using unmutated IL4 NF-AT/ 
AP-1 multimers and eliminating the contribution of AP-1 
proteins by cotransfecting in dominant-negative mutants 
of FosB and cJun. In contrast, no such inhibition was seen 
using multimer constructs in which the AP-1 sites were 
mutated. Thus, the contribution of AP-1 proteins to NF-AT- 
mediated transactivation occurs directly through the AP-1 
binding siteof the NF-AT/AP-1 compositeelement, and not 
indirectly, by mechanisms such as upregulating NF-AT 
or basal transcription factors. It is apparent from these 
findings that AP-1 proteins play a significant role in NF-AT- 
mediated induction of both the IL4 NF-AT/AP-1 composite 
site and the entire IL4 promoter. 
The OAP binding site was first characterized in the IL-2 
promoter as binding a complex called OAP40 (later found 
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to consist of the Jun family members, c-Jun and JunD), 
in a manner that was calcium regulated and cyclosporin 
A sensitive (Ullman et al., 1991, 1993). Although able to 
bind to the OAP site by itself, there was evidence to sug- 
gest that OAP40 interacted cooperatively with Ott-1 . This 
is in contrast with the factors that bind to the OAP site in 
the NF-AT/AP-1 composite element of the IL4 promoter; 
an AP-1 complex inducible in a PMA-dependent, calcium- 
independent, and cyclosporin A-insensitive manner, 
which is unable to bind in the absence of NF-AT. Precisely 
why the OAP sites in the IL-2 ARRE-1 and IL4 NF-AT/ 
AP-1 composite site confer different patterns of inducibility 
remains unknown, but may be related to the cooperative 
interactions with other DNA-binding proteins. 
It has been previously reported on the basis of gel shift 
assays that an NF-AT component lacking an AP-1 compo- 
nent binds to the IL4 NF-AT site spanning -67 to -74 
(Rooney et al., 1994). These studies used an oligonucleo- 
tide spanning -60 to -79, and thus was lacking the OAP 
binding site located from -64 to -91. As a consequence, 
only a lower complex, and not an upper complex con- 
taining NF-AT and AP-1 components, was seen. When an 
oligonucleotide containing the OAP40 binding site is used 
in gel shift assays, an upper complex consisting of NF-AT 
and AP-1 is obtained (Figure 48). It is now becoming clear 
that most, if not all, NF-AT binding sites in cytokine pro- 
moter regulatory regions are accompanied by nearby sites 
that bind auxiliary transcription factors, such as AP-1 (re- 
viewed by Rao, 1994). Although AP-1 does not bind near 
the most proximal NF-AT site of the IL-4 promoter, the 
binding site for the newly characterized constitutive DNA- 
binding complex, pigeon cytochrome C (Hodge et al., 
1995), overlaps this NFAT site, suggesting that pigeon 
cytochrome C may interact with NF-AT. Until this study, 
the precise role of NFAT in the total NF-AT-mediated 
transactivation has remained unknown. It might have been 
postulated that NF-AT serves merely as a “docking pro- 
tein” that lacks any ability to transactivate on its own, and 
functions by recruiting auxiliary transcription factors such 
as AP-1. This work shows that the NF-AT component alone 
is able to induce promoter activity, and that this activation 
is augmented by the AP-1 component. 
T helper cells are divided into two subsets expressing 
distinct patterns of cytokines. The -157 to +66 IL4 pro- 
moter fragment is faithfully expressed in a Th2-specific 
manner (Figure 6). The possibility thus arose that the IL4 
NF-ATIAP-1 site, located within this promoter region, 
could confer Th2-specific expression, perhaps by binding 
different factors in Thl and Th2 cells. Antibodies to NF- 
ATp indicated that, although it is now known that several 
NF-AT species exist, this NF-AT protein bound in both T 
helper subsets (Rooney et al., 1993; Figure 6). Further- 
more, DNAse I footprint studies indicated that two different 
NF-AT proteins, NF-ATp and NF-ATc, bound equally well 
to this site. When the AP-1 constituents were analyzed, 
however, it was found that different AP-1 proteins bound 
to the OAP site of the IL4 NF-AT/AP-1 composite element 
(namely, Fra-1 , Fra-2, JunB, and JunD) compared with that 
previouslydocumentedfortheIL-2 NF-AT/AP-1 composite 
element (c-Fos, Fra-1, Fra-2, and JunB). However, 1 
the differential recruitment of AP-1 family members to 
IL-2 or IL4 NFATIAP-1 composite sites may be conferi 
Thl/Th2 specificity seems unlikely for two reasons. F 
the composite sites function identically, either when m 
merized in front of a heterologous promoter (data 
shown), or within the context of both IL-2 or IL4 promo 
(Figure 6) as determined by transfection studies u! 
both Thl and Th2 cell clones. Second, cotransfectioi 
expression vectors containing cDNAs encoding sev 
different AP-1 proteins (c-Fos, cJun [Figure 5a], Fc 
Fra-1, Fra-2, JunB, and JunD [data not shown]) are r 
to transactivate multimerized IL4 NF-ATIAP-1 constru 
Similar transfection experiments have shown that cotrc 
fection of c-Fos, Fra-1, cJun, JunB, and JunD arc 
equally able to augment the expression of IL-2 NF- 
AP-1 multimer constructs (Jain et al., 1992; Northrop 
al., 1993; Boise et al., 1993). Also, the normal developn 
and cytokine production (including IL-2 and 114) of per 
eral T cells in c-Fosdeficient mice suggests that o 
c-Fos family members can substitute functionally for c- 
in these roles (Jain et al., 1994). Nonetheless, altho 
AP-1 proteins do not likely determine Thl/ThP specif 
via the NF-AT/AP-1 composite elements in the IL-2 
IL4 promoter, they do play a significant role in the gen 
activity of these promoters. 
Expetimental Procedursa 
cell culture 
The generation and maintenance of the Thl cell clone AE7 spc 
for pigeon cytochrome C in the context of I-EL, and the Th2 cell f 
DlO.G4.1 (DIO) (American Type Culture Collection, Rockville. I 
land) specific for conatbumin in the context of I-Ak have been desc 
(Hecht et al., 1993; Kaye et al., 1993). In brief, Th cell clones tha 
been allowed to rest and were not proliferating were stimulated f 
2 weeks with antigen and irradiated syngeneic splenocytes from 
mice as antigen-presenting cells. a-Methylmannoside-containin 
pernatant (KS) from rat spleen cells that had been stimulated 
concanavalinAfor49hrwasaddedat lO%asasourceoflymphok 
to complete media consisting of RPM1 1940 medium supplemt 
with 10% fetal calf serum (Hycfone, Logan, Utah), 2 mM glutar 
100 U/ml penicillin, 100 p@ml streptomycin, and 30 pM Bmerc 
ethanol. The ThllTh2 patterns of cytokine expression was roui 
checked by performing reverse transcrlptase-polymerase chain 
tion (RT-PCR) with primers specific for 11-2. IL4, IFNy, and 9-tul 
Cells were treated with anti-CD3 (Xl l)-coated plates (coatec 
us/ml in 1 x phosphate-buffered saline [pH 7.41) overnight at 
and then washed extensively with 1 x phosphate-buffered salin 
addition of 1 uM ionomycin (Calbiochem Corp., La Jolla, Califo 
and/or 10 rig/ml PMA (Sigma), and/or cyclosporin A (gift from t 
Abbas, Harvard Medical School). 
Reporten, Expreaelon Vectors, and trans?ectlom 
The IL4 fragment from -157 to +99 was generated by PCR 
subcloned genomic IL4 sequences, and was subcloned into thl 
and Xbal sites of the reporter plasmid, pSVD-CATapoly (Sakun 
Strominger, 1999). The murine IL-2 promoter fragment from -: 
-7 was generated by PCR from the plasmid, plLCAT0 (Serffing 
1999) which contains a 2 kb IL-2 promoter fragment, and war 
subcloned into the Sall and Xbal sites of pSVD-CATapoly. The 
linker-scanning mutations and the IL-2AL-4 NF-AT switch cons 
were generated by PCR using the method of Mikaelian and Ser 
(1992). Multimer constructs were made by directionally ligatir 
nealed synthesized oligonucleotides via their Spel and Xbal 
cutting with Spel and Xbal. gel-purifying Smers by PAGE, and sul 
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ing into the Spel-Xbal sites of the plasmid, pBLCAT2 (Luckow and 
Schutz, 1967). All constructs were sequenced on both strands to verify 
sequence integrity. Expression plasmids containing the murine full- 
length cDNAs encoding c-Fos, FosB. Fra-I, Fra-2, cJun, JunB, and 
JunD in the vector pMEX-Neal (Martin-Zanca et al., 1989) were a 
gifl from R. Bravo. The dominant negative AFosB (Nakabeppu and 
Nathans, 1991) and JunAQ (Lloyd et al., 1991) expression constructs 
were made by subcloning the cDNAs encoding AFosB and JunA9 into 
pMEX-Neal. Plasmids were purified by two cesium chloride gradient 
fractionations. 
AE7 or DlO cells were transiently transfected by preincubating 20 
pg of each plasmid with 400 ul of cells (4.8 x lO’cells/ml) in unsupple- 
mented RPM1 1640 media for 10 min at room temperature, and then 
electroporated at 290 V, 960 uF, or 270 V. 960 uF, respectively. The 
sampleswere immediately put on ice for 10 min, and then wereallowed 
to recover overnight in 10 ml complete media (including 10% RCS) 
before being treated with stimulatory agents for 24 hr. Cells were har- 
vested by three rounds of freeze-thaw and CAT assays were per- 
formed as previously described (Gorman et al., 1982). Acelyiated and 
unacetylated forms of [“Cjchloramphenicol were separated by thin 
layer chromatography and acetylation quantified by autoradiography 
and liquid scintillation counting. 
DNAse I Footprintlng 
DNA templates were made by digesting the IL4 promoter constructs 
used in transfections with Xbal, filling in with [“P]dCTP and Klenow, 
cutting with Sall, and gel-purifying by PAGE followed by overnight 
elution and ethanol precipitations. Approximately 100,000 cpm of 
probe (2-5 ng) was incubated with varying amounts of recombinant 
proteins for 10 min at room temperature in a total volume of 50 ul of 
25 mM HEPES (pH 7.9), 100 mM KCI, 12.5 mM MgCi,, 0.05 mM EDTA, 
1 .O mM DTT, 10% glycerol, 2% polyvinyl alcohol, and 0.5 ug of poly(dl- 
dC). We added 50 fit of 10 mM MgCI?, 5 mM CaCI, along with varying 
dilutions of DNAse I. After 2 min of DNAse I digestion, the reactions 
were stopped by the addition of 100 ul of Stop mix consisting of 200 
mM NaCI, 20 mM EDTA, 1% SDS, and 50 @ml 1RNA. Samples were 
then phenol extracted, ethanol precipitated, and resuspended in ioad- 
ing buffer (0.1% bromophenoi blue, 0.1% Xylene cyanol, 90% for- 
mamide). Equivalent number of counts from each sample were dena- 
tured at 90°C for 3 min and loaded onto a 6% polyacrylamide-42% 
ureagel, runa Wfor3hr,dried, andexposedovernighttoautoradio- 
graphic film. Maxam-Gilbert A/G ladders were run along side the 
DNAse I-treated samples. 
Recombinant Proteins 
Escherichia coii expression vectors for each NF-AT protein were con- 
structed in the T7 polymerase expression vector pT7-HMK, which has 
an 8 aa (MSRRASVH) heart muscle kinase site at the N terminus. 
pT7-HMK was constructed by G. Peterson. Ndel siteswere introduced 
in the coding regions upstream of the NF-AT Rel domains, and these 
sites were subsequently used for cloning into pT7-HMK. The sizes 
of the different proteins (without the heart muscle kinase sequences) 
are as follows: NF-ATp, 353 aa (the residues homologous to 186-537 
according to the numbering scheme in McCaffreyet al., 1994); NF-ATc, 
309 aa (amino acids 408-716 according lo the numbering scheme of 
Northrop et al., 1994). 
Proteins were expressed using the T7 polymerase expression sys- 
tem in the strain BL21(DE3) (Studier and Moffat, 1986). Cells were 
induced by the addition of 0.4 mM IPTG and incubated for 4 hr at 
room temperature. The cells were harvested, resuspended in 0.4 M 
KCI-HEG (25 mM HEPES [pH 7.91,O.i mM EDTA, 10% glycerol, 0.2% 
NP-40,2 mM DTT) and lysed bysonication. 
The iysate was spun at 10,000 rpm for 10 min to remove insoluble 
material. NF-AT proteins were purified from the soluble fractions of 
the extracts by DNA affinity chromatography (Kadonaga and Tjian, 
1986). The binding site sequence for the affinity resin was from the 
IL4 promoter, TACATTGGAAAATllTAlTACAC. The DNA was bio- 
tinylated on one strand and coupled to avidin-agarose beads at a 
concentration of approximately 1 mg DNA/ml. Approximately 10 mg 
of E. coli extracts containing the recombinant NF-AT proteins were 
loaded on 1.5 ml DNA columns equilibrated with 0.1 M KCI-HEG. 
The columns were washed successively with 0.1, 0.2. and 0.4 M 
HEG. The specifically bound NF-AT proteins were eluted with 1 .O M 
KCI-HEG. 
cJun protein was expressed in E. coli and purified from the insoluble 
portion of the extract as previously described (Bohman and Tjian. 
1989). c-Fos protein was provided by J. Blenis. The concentrations 
of the purified proteins were determined by comparing the intensity 
of coomassie staining with the staining of bovine serum albumin stan- 
dards. 
Electrophoretic Mobllity Shift Assays 
Small-scale nuclear extracts were made from 2 x 10’ unactivated or 
activated cells by a modification (Jamieson et al., 1991) of the method 
by Dignam et al. (1983). Protein determinations were done by the 
method of Bradford (1976) using bovine serum albumin as a standard. 
Binding assays were performed at room temperature for 30 min using 
2 ug nuclear protein extracts and 1 fmol of radiolabeled oligonucleo- 
tides in a 10 pi volume containing 8 mM HEPES (pH 7.4), 0.3 mM 
MgCI,, 100 mM NaCI, 10 mM KCI, 0.8 mM EDTA, 0.5 mM DTT, 9% 
glycerol, and 1 ug poiy (dldC), of which 5 pl were loaded on a 0.25 x 
TBE, 4% nondenaturing poiyacrylamide gels. For supershift experi- 
ments, 2 ug of nuclear extracts were preincubated for 1 hr at 4OC with 
2 pg of antibody, whereupon probe was added and binding reactions 
were allowed to continue for 30 min at room temperature. Antibodies 
used include monoclonal antibodies raised against and specific for 
c-Fos, FosB, Fra-I, Fra-2, cJun, JunB, JunD(SantaCruz Biotechnical, 
incorporated, La Jolla, California), polyclonal antisera specific for Fra-1 
and cJun (T. Curran), polyclonal antisera specific for JunB and JunD 
(R. Bravo), and poiyclonal antisera specific for the NT72 tryptic peptide 
of NF-ATp (McCaffrey et al., 1993). 
Oligonucleotides used in electrophoretic mobility shift assays 
(EMSA) analyses include from -88 to -61 of the murine IL-4 promoter: 
5”TGGTGTAATAAAATTTTCCAATGTAAA-3’; and from -79 lo -61: 
5”ATAAUll-ITCCAATGTAAA-3’. The (-88 to -61) mutant variants 
contain the same base pair changes as those in the promoter CAT 
constructs (Figure 1). The oligonucleotide containing the murine IL-2 
distal NF-AT site spans the region from -295 to -267: 5’-GCC- 
CAAAGAGGAAAATTTGITTCATACAG-3’. The oligonucleotide that 
contains the MRE corresponds lo the region in the human metallo- 
thionein IIA promoter containing the AP-1 site (Angel et al., 1967): 
5’GAGCCGCAAGTGACTCAGCGCGGGGCG-3’. 
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